Nov. 11, 2024 — Researchers have discovered a new way in which RAS genes, which are commonly mutated in cancer, may drive tumor growth beyond their well-known role in signaling at the cell surface.

According to experts, myeloma – a rare blood cancer, happens when healthy plasma cells become abnormal cells that multiply and produce abnormal antibodies. This change starts a cascade of medical ...

Three years since he was diagnosed with multiple myeloma, KARE 11's Boyd Huppert says he is cancer-free. The 62-year-old, ...

Cesar Rodriguez, MD, discussed several key aspects of talquetamab use in the treatment of relapsed/refractory multiple ...

The Connecticut resident said she’s a woman of strong faith who believes in the power of prayer and that’s all that helped to ...

A treatment approach harnessing bispecific antibodies to target cancerous cells unlocks new possibilities for patients, says ...

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

The Department of Veterans Affairs has started the process to designate multiple myeloma and acute and chronic ... return home to suffer from permanent effects of poisonous chemicals," Biden ...

Rheumatoid arthritis (RA) can affect many different body systems ... there are studies that have mentioned effects to some degree. One German study mentioned in this report found that around 27% of ...

Effects on Ability to Drive and Operate ... With a deep understanding of the human body’s immune response to tumor cells and how to translate cell therapies into practice, we’re applying this ...

Affecting approximately 4,500 people annually in the U.S., AL amyloidosis can be associated with blood cancers, particularly multiple myeloma ... on plasma cells and can have a direct effect ...